Pomegranate inhibits hormone-dependent breast cancer cell growth
A report published in the January, 2010 issue of the American Association for Cancer Research journal Cancer Prevention Research reveals the discovery by researchers at City of Hope Hospital in Duarte, California of a suppressive effect for compounds found in pomegranate on the proliferation of breast cancer cells. Prior research has demonstrated that ellagic acid in pomegranates inhibits the enzyme known as aromatase that converts androgen to estrogen hormones which fuel a common type of breast cancer.
City of Hope Division of Tumor Cell Biology director and Breast Cancer Research Program co-leader Shiuan Chen, PhD, along with Beckman Research Institute fellow Lynn Adams and their associates found that ten ellagitannins occurring in pomegranates had the potential to prevent estrogen-responsive breast cancer, with a metabolite of ellagic acid called urolithin B significantly inhibiting the growth of cultured breast cancer cells.
"Phytochemicals suppress estrogen production that prevents the proliferation of breast cancer cells and the growth of estrogen-responsive tumors," Dr Chen explained.
"We were surprised by our findings," he remarked. "We previously found other fruits, such as grapes, to be capable of the inhibition of aromatase. But, phytochemicals in pomegranates and in grapes are different."
University of Texas M.D. Anderson Center Clinical Cancer Prevention Department Chairman Powel Brown, MD, PhD is intrigued by the study's results. "More research on the individual components and the combination of chemicals is needed to understand the potential risks and benefits of using pomegranate juice or isolated compounds for a health benefit or for cancer prevention," he stated. "This study does suggest that studies of the ellagitannins from pomegranates should be continued."
He suggested that people "might consider consuming more pomegranates to protect against cancer development in the breast and perhaps in other tissues and organs."
Breast tumors often require hormones for growth, which poses a unique problem because the hormones involved in tumor growth are either estrogen, progesterone, or both. Estrogen and progesterone are naturally occurring and necessary hormones, produced mainly in the ovaries and adrenal glands in varying amounts throughout a woman's lifetime. These hormones are essential for many physiological functions, such as bone integrity.
Hormone receptor-positive tumors can consist of cancer cells with receptor sites for estrogen, progesterone, or both. The hormones attach to receptor sites and promote cell proliferation. Hormone therapy blocks the hormones from attaching to the tumor receptor sites and may slow or stop the cancer's growth. The drug most often used in this type of endocrine therapy is tamoxifen, with a response rate from 30-60%. Other therapies are sometimes used, such as aromatase inhibitors (that inhibit the conversion of precursors to estrogens) or oophorectomy (the removal of the ovaries).
The stronger form of estrogen, estradiol, can be converted into the weaker form, estriol, in the body without using drugs. Estriol is considered to be a more desirable form of estrogen. It is less active than estradiol, so when it occupies the estrogen receptor, it blocks estradiol's strong "growth" signals. Using a natural substance, the conversion of estradiol to estriol increased by 50% in 12 healthy people (Michnovicz et al. 1991). Furthermore, in female mice prone to developing breast cancer the natural substance reduced the incidence of cancer and the number of tumors significantly. The natural substance was indole-3-carbinol (I3C).
Indole-3-carbinol (I3C) is a phytochemical isolated from cruciferous vegetables (broccoli, cauliflower, Brussels sprouts, turnips, kale, green cabbage, mustard seed, etc.). I3C given to 17 men and women for 2 months reduced the levels of strong estrogen, and increased the levels of weak estrogen. But more importantly, the level of an estrogen metabolite associated with breast and endometrial cancer, 16-a-hydroxyestrone, was reduced by I3C (Bradlow et al. 1991).
Natural Appetite Control (Stimulant Free)
Hunger is the factor that often precludes most people from even considering a low-calorie diet. The remarkable news is that pinolenic acid, a polyunsaturated fatty acid found in Korean pine, has been shown to suppress appetite dramatically without causing any stimulatory effect.
Pinolenic acid stimulates the release of two of the body’s most powerful hunger-suppressing hormones: CCK (cholecystokinin) and GLP-1 (glucagon-like peptide-1). This not only helps the body digest fats better, but also sends a feeling of satiety or “fullness” to the brain, decreasing the desire to eat and helping to control excessive calorie intake.* People taking this oil had an increase in the satiety hormones CCK and GLP-1 in the bloodstreams and a reduced desire to eat by 36%.
*This supplement should be taken in conjunction with a healthy diet and regular exercise program. Results may vary.
Ultra Rejuvenex® is an extraordinary youth-promoting face cream that contains green and white tea extracts, along with many other beneficial nutrients for the skin. Scientific studies reveal that tea extracts promote healthy-looking skin.
For example, one study showed that green tea promotes younger looking skin by protecting skin against oxidative stress. Topical application with green tea extract also reduces the appearance of wrinkles.
Alpha-hydroxy acids were long ago documented to remove coarse dead cells at the skin’s surface, thereby exposing the youthful-looking cells beneath. Some people, however, experience irritation using large amounts of these acids. To resolve this problem, Ultra Rejuvenex provides a balanced combination of alpha- and beta-hydroxy acids. The beta-hydroxy acids remove dead cells at the skin’s surface without causing irritation.